Viewing Study NCT00327093

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2026-01-22 @ 12:12 PM
Study NCT ID: NCT00327093
Status: TERMINATED
Last Update Posted: 2009-02-09
First Post: 2006-05-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases
Sponsor: Hospices Civils de Lyon
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
None Neoplasm Metastasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Colorectal cancer, View
None immunohistochemistry, View
None monoclonal antibodies, View
None predictive model, View
None antiangiogenic agents, View
None medical imaging View
None Colorectal cancer with liver metastases View